In this real-world case study, three investors examine the valuation of a clinical-stage biotech company using three different methods. However, they arrive at similar conclusions.
PEVC case study: Biotech investment with a complex capital structure
Sep 30, 2020 · 25 min watch
SECTION + CREDENTIAL
Reserved for CEIV Credential Holders, FVS Section Members, PEVC Content Subscriptions and Valuations Subscriptions
Already a FVS Section Member? Or a CEIV Credential Holder? Or a PEVC Content or Valuations Subscriber?
Log in with your account
Not a FVS Section Member? Or a CEIV Credential Holder? Or a PEVC Content or Valuations Subscriber?
To gain access to exclusive content, your first step is to join the AICPA.
Discover the benefits of: